[go: up one dir, main page]

IT8419995A0 - Procedimento selettivo per il blocco di ricettori di 5ht2. - Google Patents

Procedimento selettivo per il blocco di ricettori di 5ht2.

Info

Publication number
IT8419995A0
IT8419995A0 IT8419995A IT1999584A IT8419995A0 IT 8419995 A0 IT8419995 A0 IT 8419995A0 IT 8419995 A IT8419995 A IT 8419995A IT 1999584 A IT1999584 A IT 1999584A IT 8419995 A0 IT8419995 A0 IT 8419995A0
Authority
IT
Italy
Prior art keywords
receptors
block
selective procedure
selective
procedure
Prior art date
Application number
IT8419995A
Other languages
English (en)
Other versions
IT1209512B (it
Inventor
Marlene Lois Cohen
Ray Ward Fuller
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8419995A0 publication Critical patent/IT8419995A0/it
Application granted granted Critical
Publication of IT1209512B publication Critical patent/IT1209512B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Holo Graphy (AREA)
  • Eye Examination Apparatus (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Prostheses (AREA)
IT8419995A 1983-03-10 1984-03-09 Procedimento selettivo per il blocco di ricettori di 5ht2. IT1209512B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/473,882 US4563461A (en) 1983-03-10 1983-03-10 Selective method for blocking 5HT2 receptors

Publications (2)

Publication Number Publication Date
IT8419995A0 true IT8419995A0 (it) 1984-03-09
IT1209512B IT1209512B (it) 1989-08-30

Family

ID=23881404

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8419995A IT1209512B (it) 1983-03-10 1984-03-09 Procedimento selettivo per il blocco di ricettori di 5ht2.

Country Status (6)

Country Link
US (1) US4563461A (it)
EP (1) EP0122044B1 (it)
JP (1) JPS59175431A (it)
AT (1) ATE35506T1 (it)
DE (2) DE3408730A1 (it)
IT (1) IT1209512B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
US4810710A (en) * 1985-10-01 1989-03-07 Eli Lilly And Company 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine
US4683236A (en) * 1985-10-01 1987-07-28 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
US4714704A (en) * 1985-10-01 1987-12-22 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4820713A (en) * 1985-10-01 1989-04-11 Eli Lilly And Company Ketoalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4939258A (en) * 1985-10-01 1990-07-03 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4847261A (en) * 1985-10-01 1989-07-11 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists properties
US4762842A (en) * 1985-10-01 1988-08-09 Eli Lilly And Company Selective method for blocking 5HT2 receptors
IL80193A0 (en) * 1985-10-01 1986-12-31 Lilly Co Eli Esters of dihydrolysergic acid
US4968802A (en) * 1985-10-01 1990-11-06 Eli Lilly And Company Process of making alkoxy cycloalkanol esters of dihydrolysergic acid
US4845224A (en) * 1985-10-01 1989-07-04 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
US4906639A (en) * 1985-10-01 1990-03-06 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4713385A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US4683237A (en) * 1985-12-20 1987-07-28 Eli Lilly And Company Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
US4704396A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Phenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonists
US4704395A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Cyclic ether esters of 2-substituted-6-(substituted and unsubstituted) dihydrolysergic acid useful as 5HT receptor antagonists
EP0228876A3 (en) * 1985-12-20 1989-03-22 Eli Lilly And Company Esters of dihydrolysergic acid and related compounds
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
US5688807A (en) * 1994-03-11 1997-11-18 Eli Lilly And Company Method for treating 5HT2B receptor related conditions
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
US3249617A (en) * 1966-05-03 Alkylated d-lyserglc acid
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
GB1290203A (it) * 1970-09-01 1972-09-20
BE792515A (fr) * 1971-12-10 1973-06-08 Sandoz Sa Nouveaux derives de l'acide lysergique, leur preparation et leur application comme medicaments
JPS5443649B2 (it) * 1973-06-05 1979-12-21
US4153700A (en) * 1975-08-27 1979-05-08 Lake Shore Roentgenology Ltd. Treatment of the acute after-effects resulting from alcohol ingestion
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Also Published As

Publication number Publication date
JPS59175431A (ja) 1984-10-04
EP0122044B1 (en) 1988-07-06
US4563461A (en) 1986-01-07
IT1209512B (it) 1989-08-30
EP0122044A1 (en) 1984-10-17
ATE35506T1 (de) 1988-07-15
DE3472529D1 (en) 1988-08-11
DE3408730A1 (de) 1984-09-13

Similar Documents

Publication Publication Date Title
IT8419995A0 (it) Procedimento selettivo per il blocco di ricettori di 5ht2.
DK345684A (da) Analgetisk middel
IT8322801A0 (it) Procedimento per la produzione di idrocarburi.
NO171251C (no) Dusjhode
FI842889A0 (fi) Partikelsuspensioner foer immunoglutination.
FI844804A7 (fi) Menetelmä tekijän VIII:C puhdistamiseksi.
FI834741A0 (fi) Slirskyddsanordning, speciellt foer luftfyllda fordonsdaeck pao is- och snoeytor
IT8421487A0 (it) Blocco di allaciamento.
FI842621A0 (fi) Skidbindning speciellt foer terraengskidning.
DE3482685D1 (de) Leukotrien-antagonisten.
IT1206143B (it) Procedimento per produrre dispositivi semiconduttori.
IT8423765A0 (it) Procedimento per produrre 4-alcossianiline.
IT8467224A1 (it) Procedimento per il posizionanento di utensili.
IT1179247B (it) Procedimento per produrre interferone
IT1196092B (it) Mezzi di dissuasione per uccelli
IT8322380A0 (it) Apparecchio igienico-sanitario.
IT8421149A1 (it) Procedimento migliorato per il disproporzionamento di clorosilani
IT8422145A0 (it) Procedimento per la produzione di beta-fenilserina.
IT8421695A1 (it) Procedimento per la preparazione di 3,11-dimetil-2-nonacosanone
IT8321953A0 (it) Teofillin-7-acetato di ambroxolo.
FI844067A7 (fi) Menetelmä 9-karbamoyylifluoreeni-johdannaisten valmistamiseksi.
ES521588A0 (es) Procedimiento de obtencion de nuevas n-ciano-formamidinas.
IT8424230A0 (it) Procedimento per la preparazione di 3,4,5-trimetossi-benzonitrile.
DK380383D0 (da) Hjaelpeudstyr til badekar
IT1196176B (it) Procedimento per la preparazione di 29-idrossi-3,11-dimetil-2-nonacosanone